News

Filter

Current filters:

None

Popular Filters

7912 to 7936 of 8761 results

Timothy Wright named global head, development, at Novartis Pharma

09-11-2011

Swiss drug major Novartis (NOVN: VX) announced the appointment of Timothy Wright, as global head, development,…

ManagementNovartisPharmaceutical

Number of monoclonal antibody products in development continues to increase, says Tufts CSDD

09-11-2011

Developers are steadily increasing the number of monoclonal antibody products - known as MAbs - for which…

BiotechnologyImmunologicalsOncologyResearch

Disappointment for AstraZeneca and Targacept as antidepressant fails to meet Ph III endpoint

09-11-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and Targacept (Nasdaq: TRGT) yesterday reported disappointing…

AstraZenecaNeurologicalPharmaceuticalResearchTargacept

Transgene to seek partner for HCV vaccine TG4040 on strong Ph II results

09-11-2011

French biotech firm Transgene (Euronext Paris: FR0005175080) has revealed interim data showing a substantial…

BiotechnologyLicensingOncologyPharmaceuticalResearchTransgeneVaccines

Strong 3rd-quarter 2011 sales growth at Lundbeck, but write-off hits profit

09-11-2011

Danish CNS drug specialist Lundbeck (LUND: DC) has reported a strong set of financial results for the…

FinancialLundbeckNeurologicalPharmaceutical

Tranzyme Pharma extends drug discovery collaboration with Bristol-Myers Squibb

09-11-2011

USA-based Tranzyme Pharma (Nasdaq: TZYM) says it has extended its chemistry-based drug discovery collaboration…

Bristol-Myers SquibbLicensingPharmaceuticalResearchTranzyme

Amgen shares jump as firm unveils plans for a $5 billion stock purchase

08-11-2011

USA-based Amgen (Nasdaq: AMGN), the world’s largest independent biotech firm, saw its shares leap…

AmgenBiotechnologyFinancial

Will the USA’s Hatch-Waxman lock be sprung in 2012? asks HP&M lawyer

08-11-2011

In the USA, there have been rumors for several weeks that, once the ball gets rolling in Congress with…

GenericsLegalNorth AmericaPharmaceuticalPoliticsRegulation

Recordati’s Normosang now approved in Russia; posts strong financials

08-11-2011

Italian drugmaker Recordati (REC: MI) and wholly-owned subsidiary Orphan Europe announced that Normosang,…

EuropeFinancialNormosangPharmaceuticalRare diseasesRecordatiRegulation

Another call for reform of Canada’s pharma intellectual property laws

08-11-2011

Canada's pharmaceutical intellectual property laws need major reform to encourage and protect innovation…

North AmericaPatentsPharmaceutical

South Korean govt to slash drug prices 14%

08-11-2011

South Korea’s Ministry of Health and Welfare has issued an advance notice of the legislation of…

Asia-PacificPharmaceuticalPoliticsPricingResearch

FDA accepts VIVUS NDA filing for Qnexa with PDUFA set for April 2012

08-11-2011

There was good news for US drugmaker VIVUS (Nasdaq: VVUS) in its long-running battle to get its weight-loss…

MetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

Added indication for Bristol-Myers’ Erbitux approved by FDA

08-11-2011

The US Food and Drug Administration yesterday approved US drug major Bristol-Meyers Squibb’s (NYSE:…

Bristol-Myers SquibbErbituxNorth AmericaOncologyPharmaceuticalRegulation

Ph III study shows Novartis’ canakinumab substantially reduces steroid use in children with SJIA

08-11-2011

Swiss drug major Novartis (NOVN: VX) says new pivotal Phase III data show that 45% of children with active…

Anti-Arthritics/RheumaticsCanakinumab InjectionIlarisNovartisResearch

Vertex’ Incivek set to break record for fastest product launch

08-11-2011

Vertex Pharmaceuticals’ (Nasdaq: VRTX) new hepatitis C drug Incivek (telaprevir) is being touted…

FinancialIncivekMarkets & MarketingPharmaceuticalVertex

Novo Nordisk says DegludecPlus provides superior glycemic control vs Lantus

07-11-2011

Denmark-based insulin giant Novo Nordisk (NVO: N) yesterday announced positive clinical results from…

DegludecDegludecPlusDiabetesLantusNovo NordiskPharmaceuticalResearchSanofi

Small-molecule cancer drug revenues set to reach $27.3 billion in 2015, predicts Visiongain

07-11-2011

Rising disease prevalence, along with advances in pharmacotherapy and diagnostics, will stimulate the…

Markets & MarketingOncologyPharmaceutical

Study identifies factors linked with better medication response for treatment of juvenile arthritis

07-11-2011

Among patients with juvenile idiopathic arthritis (JIA) who initiated treatment with the drug etanercept…

AmgenAnti-Arthritics/RheumaticsEnbreletanerceptPfizerPharmaceuticalResearch

Pfizer returns rights to TNF-alpha targeting nanobodies to Ablynx

07-11-2011

Shares of Belgian drug developer Ablynx [Euronext Brussels: ABLX] fell 18.2% to 2.93 euros in morning…

AblynxAnti-Arthritics/RheumaticsLicensingozoralizumabPfizerPharmaceutical

Teva to continue selling Viagra generic in Russia

07-11-2011

Israel-basedTeva Pharmaceutical Industries (Nasdaq: TEVA) managed to avoid a high-profile confrontation…

DynamicoEuropeGenericsMarkets & MarketingPatentsPfizerPharmaceuticalReproductiveTeva Pharmaceutical IndustriesViagra

7912 to 7936 of 8761 results

Back to top